Nu Skin Enterprises: stocks, financial statements

Disable ads for free
Dividends News
Favorites

An American marketing company that develops and produces cosmetic and Wellness products. Specializes in anti-aging care cosmetics and food additives. It is a direct sales company that distributes its products through 1.2 million independent distributors in 54 countries. According to the company, it pays about 43 percent of the revenue from its products as compensation for sales. 

The Nu Skin brand of the same name produces more than 200 items of personal care products. After the acquisition of Generation Health, the company launched the production of food additives with a high content of carotenoids under the brand name Pharmanex. It also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight control and body shaping systems, and other anti-aging nutritional solutions.

Utah is home to the corporation's innovation center, which includes five research laboratories. Additionally, the company operates retail stores and service centers in mainland China.

  • NUS Ticker
  • NYSE Exchange
  • 44,900 Employees
7 rated
  • $52.50, +$0.43 (+0.83%) Previous Close
  • 143,520 Previous Volume
  • $12.21 / $55.71 52 week low / high
  • -5.76% Percent off 52 week high
  • 2020-11-27 Updated
  • 2.85% Dividend Yield (trailing)
  • 2.86% Dividend Yield (forward)
  • 0 Public float
  • 51,030,963 Outstanding shares
  • 0.00 P/E
  • 2.68 B Market Cap
Disable ads for free

Financial statements — Nu Skin Enterprises

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
19 ← 15 2019 2018 2017 2016 2015
Total Revenue
2.4B 2.7B 2.3B 2.2B 2.2B
Cost Of Revenue
580M 630M 500M 540M 560M
Gross Profit
1.8B 2B 1.8B 1.7B 1.7B
Research and Development
30M 23M 22M 24M 20M
Selling General and Admin
1.5B 1.7B 1.5B 1.4B 1.4B
Operating Expense
2.2B 2.4B 2B 1.9B 2B
Operating Income
270M 310M 270M 260M 240M
Other Income Expense Net
-12M -92M -8.4M -49M -31M
EBIT
270M 310M 270M 260M 240M
Interest Income
19M 22M 22M 16M 7.9M
Pretax Income
260M 220M 270M 210M 210M
Income Tax
82M 98M 140M 70M 79M
Minority Interest
0 0 0 0 0
Net Income
170M 120M 130M 140M 130M
Net Income Basic
170M 120M 130M 140M 130M
19 ← 15 2019 2018 2017 2016 2015
Current cash
340M 390M 430M 360M 290M
Short term investments
8.4M 11M 12M 12M 15M
Receivables
50M 53M 33M 31M 35M
Inventory
280M 300M 250M 250M 270M
Other current assets
62M 45M 49M 54M 87M
Current assets
730M 790M 770M 710M 690M
Long term investments
39M 39M
Property plant equipment
600M 460M 460M 440M 450M
Goodwill
200M 200M 110M 110M 110M
Intangible assets
80M 90M 68M 64M 67M
Other assets
84M 71M 92M 71M 66M
Total assets
1.8B 1.7B 1.6B 1.5B 1.5B
Accounts payable
39M 48M 50M 41M 29M
Current long term debt
28M 69M 78M 83M 68M
Other current liabilities
250M 320M 310M 280M 310M
Total current liabilities
360M 440M 450M 400M 410M
Long term debt
440M 370M 320M 330M 190M
Other liabilities
76M 75M 67M 59M 42M
Minority Interest
0 0 0 0 0
Total Liabilities
890M 910M 890M 810M 680M
Common stock
56M 55M 53M 53M 56M
Retained earning
1.7B 1.6B 1.6B 1.6B 1.5B
Treasury stock
2.4M 3M 2.8M 2.9M 2M
Capital surplus
560M 550M 470M 440M 420M
Shareholder equity
880M 780M 700M 660M 830M
Net tangible assets
270M 180M 310M 280M 450M
19 ← 15 2019 2018 2017 2016 2015
Net Income
170M 120M 130M 140M 130M
Depreciation
120M 83M 72M 72M 71M
Changes in receivables
2.9M -20M -2M 4.3M
Changes in inventories
18M -33M 7.5M 9.8M 60M
Cash change
-51M -39M 69M 68M 940K
Cash flow
180M 200M 300M 280M 320M
Capital expenditures
-66M -70M -60M -50M -57M
Investments
2.7M -38M -32M 1.1M -4.2M
Investing activity other
Total investing cash flows
-71M -110M -92M -58M -61M
Dividends paid
-82M -81M -76M -78M -81M
Net borrowings
-69M 23M -36M 170M 710K
Other financing cash flows
-2.3M 5.7M 5.3M
Cash flow financing
-150M -120M -160M -130M -240M
Exchange rate effect
-3M -17M 18M -15M -24M
Disable ads for free
Disable ads for free